Cardiovascular Disease· Topic 2.3 Ischemic heart disease· 2.3.25

Microvascular angina

Microvascular angina is angina from coronary microvascular dysfunction with no obstructive epicardial disease, part of the INOCA spectrum. It causes exertional or rest chest pain with evidence of ischemia but normal angiography, is diagnosed by tests of coronary flow reserve, and is managed with risk-factor control and antianginal therapy.

4 min read3 practice questions7 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: microvascular angina is angina caused by coronary microvascular dysfunction (impaired vasodilation or microvascular spasm) in the absence of obstructive epicardial coronary disease, part…

  • Epidemiology

    More common in women. A frequent explanation for angina with non-obstructive coronaries.

  • Risk factors

    Female sex (especially post-menopausal). Traditional risk factors: hypertension, diabetes, dyslipidemia, and smoking.

  • Pathophysiology

    Microvascular dysfunction: impaired endothelium-dependent and independent vasodilation reduces the ability to augment coronary flow (reduced coronary flow reserve).

  • Clinical features

    Exertional or rest angina, often with a prolonged response to rest or nitrates.

  • Differential diagnosis

    Obstructive coronary artery disease: exertional angina with objective ischemia, distinguished by a flow-limiting epicardial stenosis on angiography, which is absent in microvascular disease (Chronic stable angina).

  • Diagnosis

    Establish by demonstrating ischemia or impaired microvascular function with non-obstructive coronary arteries: the diagnostic basis is angina with objective ischemia and non-obstructive coronaries on…

  • Management

    First-line, aggressive risk-factor control and antianginal therapy: A statin (atorvastatin 40 to 80 mg PO daily) and blood pressure control.

  • Complications

    Recurrent angina and reduced quality of life.

  • Prognosis

    Better than obstructive disease but not benign, with excess events.

  • Prevention

    Blood pressure control to a target below 130/80 mmHg.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.